Kai Zhang

Biography

Zhang_Kai
Kai Zhang is a counsel in the London Finance practice, specialising in advising private equity sponsors and their portfolio companies on a range of multijurisdictional complex financings, with a focus on leveraged buyouts of public and private companies.

Kai has extensive experience advising on European and U.S. debt financings, including transactions involving senior secured credit facilities (including unitranche financings), high yield bonds, second liens and other acquisition and holdco instruments, liability management and fund financings.

Kai has worked on secondment at Hg Capital for a year where she worked on a variety of transactions across different funds, jurisdictions and sectors, advising on leveraged finance, fund finance, M&A and other legal matters.

Kai is recognised in IFLR1000’s 2024 Women in Business Law EMEA Awards as a rising star for finance.

Languages spoken: English, Chinese Mandarin and German

Representative experience (also from previous firm) includes advising:

  • Advent International on the financing for its $8.1 billion take private offer for Swedish Orphan Biovitrum AB
  • Advent International and Eurazeo on their financing for the acquisition of Hoist and subsequent bolt on acquisitions
  • Advent International on its refinancing for Williams Lea Tag
  • Advent International on its refinancing for Donte
  • Bain Capital on its syndicated financing for the acquisition of Inetum
  • Bain Capital on its financing for the acquisition of Deltatre
  • CVC on a bespoke financing in respect of its strategic partnership with Dale Underwriting Partners
  • Permira on its financing for the acquisition of Safti
  • Lone Star on its financing in respect of a dividend recapitalisation for Altadia
  • A&M Capital on its financing for the acquisitions of Ayesa and Ibermatica
  • Hg Capital on a variety of leveraged financing and fund financing transactions, including its fund financing for Hg Saturn fund, its financings for the acquisitions of Iris Software AG, Medifox, Transporeon and ControlPay, a margin loan financing in connection with Hg’s investment in Gentrack, a fund level preferred equity investment and other bids and financing and corporate matters
  • Bridgepoint on its financing for the acquisition of Pharmazell
  • Bridgepoint on its financing for the acquisition of Vermaat Groep B.V.
  • PAI on its financing for the acquisition of Elitech
  • Charterhouse on its financing for the take private acquisition of Tarsus Group

Firm News & Announcements, Awards and Recognition, Speaking Engagements, Guides and Resources, Latest Thinking

Firm News & Announcements

View all